{"id":474574,"date":"2021-04-12T06:03:02","date_gmt":"2021-04-12T10:03:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/"},"modified":"2021-04-12T06:03:02","modified_gmt":"2021-04-12T10:03:02","slug":"angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/","title":{"rendered":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System"},"content":{"rendered":"

<\/p>\n

AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System<\/b><\/p>\n

Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature<\/i><\/b><\/p>\n

LATHAM, N.Y.–(BUSINESS WIRE<\/a>)–
\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510(k) application to the United States Food and Drug Administration (FDA) for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature.\n<\/p>\n

\nThe AlphaVac System combines two of AngioDynamics\u2019 proprietary technologies: a new mechanical aspiration handle and the Company\u2019s innovative self-expanding funnel tip and is designed to provide precise control in the removal of clot burden while minimizing patient blood loss. Undesirable intravascular material can include thrombus, embolus, and vegetation found in a patient\u2019s venous system, including the peripheral vasculature.\n<\/p>\n

\n\u201cWe are excited to announce this important milestone in the ongoing transformation of our portfolio,\u201d said Jim Clemmer, President and Chief Executive Officer of AngioDynamics. \u201cOur team developed AlphaVac in collaboration with leading physicians to enable treatment in more cases without the need for perfusion while providing control, power and versatility to drive positive patient outcomes. AlphaVac expands our thrombus management portfolio allowing us to serve a larger, fast-growing segment of the thrombectomy market and we\u2019re confident it will become a go-to treatment option for physicians.\u201d\n<\/p>\n

\nAngioDynamics anticipates the release of the AlphaVac System in the second half of calendar year 2021, subject to FDA clearance.\n<\/p>\n

About AngioDynamics, Inc.<\/b><\/p>\n

\nAngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics\u2019 diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com<\/a>.\n<\/p>\n

\nAngioDynamics and AlphaVac are trademarks and\/or registered trademarks of AngioDynamics, Inc., an affiliate or subsidiary.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210412005252\/en\/<\/a><\/span><\/p>\n

Investor Relations: <\/b><\/p>\n

\nAngioDynamics, Inc.
\n
Stephen Trowbridge
\n
518-795-1408
\n
strowbridge@angiodynamics.com<\/a><\/p>\n

Media: <\/b><\/p>\n

\nAngioDynamics, Inc.
\n
Saleem Cheeks
\n
518-795-1174
\n
scheeks@angiodynamics.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology FDA Medical Devices Health Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature LATHAM, N.Y.–(BUSINESS WIRE)– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510(k) application to the United States Food and Drug Administration (FDA) for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The AlphaVac System combines two of AngioDynamics\u2019 proprietary technologies: a new mechanical aspiration handle and the Company\u2019s innovative self-expanding funnel … <\/p>\n

Continue reading “AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-474574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature LATHAM, N.Y.–(BUSINESS WIRE)– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510(k) application to the United States Food and Drug Administration (FDA) for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The AlphaVac System combines two of AngioDynamics\u2019 proprietary technologies: a new mechanical aspiration handle and the Company\u2019s innovative self-expanding funnel … Continue reading "AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-12T10:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System\",\"datePublished\":\"2021-04-12T10:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/\"},\"wordCount\":403,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/\",\"name\":\"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-04-12T10:03:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/","og_locale":"en_US","og_type":"article","og_title":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","og_description":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature LATHAM, N.Y.–(BUSINESS WIRE)– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510(k) application to the United States Food and Drug Administration (FDA) for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The AlphaVac System combines two of AngioDynamics\u2019 proprietary technologies: a new mechanical aspiration handle and the Company\u2019s innovative self-expanding funnel … Continue reading \"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-12T10:03:02+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System","datePublished":"2021-04-12T10:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/"},"wordCount":403,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/","name":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-04-12T10:03:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210412005252r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/474574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=474574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/474574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=474574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=474574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=474574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}